Dupuytren's disease
Exam Tips
- In OSCE, demonstrate and state the tabletop test clearly; inability to place palm flat supports contracture.
- Ring and little finger MCP/PIP involvement with palmar nodules/cords is classic; DIP disease is unusual and should prompt reconsideration of diagnosis.
- Quote progression and recurrence in viva answers: treatment improves function but does not cure fibroproliferative tendency.
- Look beyond the hand for diathesis markers (Garrod pads, plantar fibromatosis, Peyronie's) and mention prognostic significance.
- Differentiate from trigger finger: Dupuytren causes fixed extension deficit from fascial cords, not painful catching from A1 pulley pathology.
Definition
Dupuytren's disease is a chronic, benign fibroproliferative disorder of the palmar and digital fascia that causes nodules and longitudinal cords in the hand. Over months to years these cords may shorten, producing fixed flexion deformity (Dupuytren's contracture), most often at the MCP and PIP joints of the ring and little fingers, with frequent bilateral involvement.
Pathophysiology
The condition is driven by genetically predisposed abnormal wound-healing biology in palmar fascia, with environmental triggers (for example smoking, alcohol excess, vibration/trauma) thought to amplify disease expression. Myofibroblast proliferation and cytokine-mediated extracellular matrix remodelling increase type III collagen deposition (replacing normal type I collagen), creating nodules that evolve into fibrotic cords. Progressive cord maturation and contraction then pull digits into flexion; disease can coexist with related fibromatoses such as Ledderhose (plantar), Peyronie's (penile), and Garrod's knuckle pads (dorsal PIP). See standard hand surgery anatomy figures showing pretendinous bands and digital cord pathways.
Risk Factors
- Increasing age (especially >40 years; prevalence rises markedly in older adults)
- Male sex
- Family history/autosomal dominant inheritance with variable penetrance
- Northern European ancestry
- Diabetes mellitus (often milder, slower-progressing phenotype)
- Smoking (dose-response relationship)
- High alcohol intake
- Epilepsy (association reported; possible link with antiseizure therapy)
- Occupational vibration/manual hand trauma
- Liver disease
- Features of Dupuytren diathesis (early onset, bilateral disease, ectopic fibromatosis)
Clinical Features
Symptoms
- Gradual hand stiffness and reduced finger extension
- Functional difficulty (for example washing face, putting on gloves, inserting hand into pockets, gripping large objects)
- Usually painless course, though early nodules may be tender/discomforting
- Perceived progression over time, sometimes asymmetrical between hands
Signs
- Palmar skin thickening, tethering, pitting, puckering, or dimpling
- Firm nodules fixed to palmar fascia/skin (classically near distal palmar crease in line with ring/little finger)
- Palpable longitudinal cords extending distally into fingers
- Fixed flexion contracture at MCP and/or PIP joints (DIP involvement uncommon)
- Positive tabletop test (unable to place palm and fingers flat)
- Ring and little fingers most commonly affected; thumb/index less commonly affected
- Possible ectopic lesions: Garrod knuckle pads, plantar nodules (Ledderhose), penile plaques (Peyronie's)
Investigations
Management
Lifestyle Modifications
- Explain natural history: progressive but variable; not all nodules rapidly progress to severe contracture
- Observe mild disease without functional limitation; monitor progression and hand function
- Smoking cessation support and alcohol reduction advice (modifiable associated factors)
- Optimize comorbidities (especially diabetes control) and occupational hand protection from repetitive vibration/trauma
- Safety-net for worsening extension loss, deteriorating function, or rapid progression (earlier hand surgery referral)
Pharmacological Treatment
Simple analgesia for tenderness/discomfort (not disease-modifying)
- Paracetamol 1 g orally every 4-6 hours when required (max 4 g/day)
Use for pain only; Dupuytren's itself is often minimally painful. Reduce maximum daily dose in low body weight, frailty, or hepatic impairment per BNF.
NSAID analgesia (short course if needed)
- Ibuprofen 400 mg orally up to three times daily with/after food (max 2.4 g/day)
Avoid/caution in peptic ulcer disease, CKD, heart failure, uncontrolled hypertension, anticoagulation, and pregnancy (especially from 20 weeks; avoid in 3rd trimester). Consider gastroprotection in high GI-risk patients.
Enzymatic cord disruption (specialist use, limited UK access)
- Collagenase clostridium histolyticum 0.58 mg intralesional injection into palpable cord (single-dose vial; specialist hand service protocol)
Not routine first-line NHS care in many regions. Risks include tendon rupture, ligament injury, significant bruising/swelling, and skin tears; avoid in local infection and use caution with bleeding risk.
Surgical / Interventional
- Percutaneous needle fasciotomy (needle aponeurotomy) for selected cords; faster recovery but higher recurrence
- Limited fasciectomy for function-limiting contracture (common operative option)
- Dermofasciectomy with skin graft in recurrent/aggressive disease or poor skin quality
- Referral to hand surgery is typically indicated for progressive functional impairment and clinically significant MCP/PIP contracture (commonly around MCP >=30 degrees or any functionally important PIP contracture)
Complications
- Progressive fixed flexion deformity causing disability and loss of dexterity
- Reduced hand function affecting work, self-care, and leisure
- Recurrence after intervention (higher after needle fasciotomy; persists after all techniques)
- Post-procedural complications: nerve or vessel injury, tendon injury/rupture, infection, haematoma, stiffness, complex regional pain syndrome
- Skin tears and wound-healing problems, especially in severe contracture or revision surgery
Prognosis
Dupuytren's disease is chronic and not curable; progression rate is heterogeneous. Many patients worsen over time, and long-term studies suggest a substantial proportion with nodules/cords eventually develop contracture, although a minority regress. Earlier onset, male sex, strong family history, bilateral/ectopic disease and radial digit involvement indicate a more aggressive diathesis. Surgery improves function but does not remove underlying disease biology, so recurrence and reintervention risk remain important counselling points.
Sources & References
🏥BMJ Best Practice(1)
✅NICE Guidelines(1)
- Dupuytren's disease[overview]